JNJ Jan 2025 210.000 put
| Previous Close | 45.50 |
| Open | 45.50 |
| Bid | 46.85 |
| Ask | 50.80 |
| Strike | 210.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 45.50 - 45.50 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
Insider MonkeyIs Johnson & Johnson (JNJ) Stock Set for Further Gains?
We recently published a list of 7 Most Profitable Cheap Stocks To Invest In. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other most profitable cheap stocks to invest in. Insights on Small Caps, Tech, and More Sherry Paul, Morgan Stanley Private Wealth Management […]
- Yahoo Finance Video
Netflix earnings, retail rales data, Fedspeak: What to watch
As the week concludes, hosts Julie Hyman and Josh Lipton preview key events investors should monitor in the coming week. Columbus Day will be observed on Monday, when the bond market (^TYX, ^TNX, ^FVX) will be closed while the stock market remains open. The third quarter earnings season continues in full force, with Big Banks such as Morgan Stanley (MS), Citigroup (C), and Bank of America (BAC) scheduled to report. Industry giants including Netflix (NFLX), Johnson & Johnson (JNJ), UnitedHealth (UNH), and ASML Holding (ASML) will also unveil quarterly results. Thursday brings the release of September retail sales data, offering fresh insights into consumer behavior. Economists anticipate a 0.3% reading, an increase from August's 0.1%. The housing market will be in focus next Friday with the release of Homebuilder Confidence and Housing Starts & Building Permits data. Investors can expect more commentary from Federal Reserve officials, with Fed Governor Christopher Waller and Fed Governor Adriana Kugler slated to speak. Their remarks should provide additional insights into the central bank's monetary policy outlook. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Angel Smith
BloombergJ&J’s Court-Shopping Win Highlights Irresistible Bankruptcy Tool
(Bloomberg) -- Johnson & Johnson’s successful use of a “court-shopping” legal tactic to advance its latest plan for resolving thousands of cancer claims spotlights a controversial bankruptcy maneuver corporations have long employed to avoid unfavorable rulings. Most Read from BloombergThe Master Plan That Shaped Pakistan’s Capital Is No Longer WorkingThe Cablebus Transformed Commutes in Mexico City’s Populous OutskirtsAs Brussels Booms, an Old Boogeyman Returns: BrusselizationChicago Marathon to
